Skip to main content

OGT Coverage in BioArray News

Premium

 

  • Add One More Defendant to OGT’s List: UK Firm Sues Motorola Over eSensor Biochip [BN 7/23/2003]
  • Axon Becomes Second Microarray-related Firm to Settle Out of Court with Oxford Gene [BN 6/25/2003]
  • OGT vs. Nanogen Heads to Mediation; Mergen Defiant While Axon Is Talking [BN 6/4/2003]
  • Oxford Gene Technology Files Suits Against a Wide Array of Companies [BN 1/3/2003]
  • Pioneering DNA Microarray Patent Upheld in Europe: Licenses Anyone?[BN 11/30/2001]

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.